The rising interest in GLP-1 agonists for metabolic conditions has led to a debate about formats: transdermal systems versus capsules. Traditionally , GLP-1 treatments were solely available in pill form, https://carlypyct669152.digiblogbox.com/65371318/glp-1-transdermal-delivery-systems-vs-tablets-is-best-for-individuals